Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region

被引:27
作者
di Iasio, MG
Calin, G
Tibiletti, MG
Vorechovsky, I
Benediktsson, KP
Taramelli, R
Barbanti-Brodano, G
Negrini, M
机构
[1] Univ Ferrara, Dept Mol & Diagnost Med, I-44100 Ferrara, Italy
[2] Univ Pavia, Dept Clin & Biol Sci, I-21100 Varese, Italy
[3] Huddinge Hosp, Dept Surg, S-14157 Huddinge, Sweden
[4] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[5] Univ Varese, Dept Struct & Funct Biol, I-21110 Varese, Italy
关键词
LOH at 11q23; breast cancer;
D O I
10.1038/sj.onc.1202453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of constitutive heterozygosity at 11q23 has been detected in various human solid tumors. Here, we described the analysis of a series of normal and tumor pairs from 110 breast carcinomas for the presence of loss of heterozygosity at 11q23 loci. The overall frequency of LOH was 48%, confirming the importance of deletions at 11q23 in breast tumorigenesis. Previously, we have identified two independent regions of LOH at 11q23, the LOH region 1 at 11q23.1 and the LOH region 2 at 11q23.3. The most telomeric region was recently refined between loci D11S1345 and D11S1316, a region of about 1 Mb. However, the LOH region 1, most centromeric, was still not finely refined: the boundaries were defined by loci D11S2000 and D11S897, separated by about 8 Mb. Here, me refined its boundaries between loci D11S1347 and D11S927, a region of about 2 Mb. We have mapped 11 expressed sequence tags (ESTs) within this region and excluded another 20. This study represents a further step toward the identification of the putative tumor suppressor gene found within the LOH region 1 at 11q23.1.
引用
收藏
页码:1635 / 1638
页数:4
相关论文
共 36 条
[1]   A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3 [J].
Arai, Y ;
Hosoda, F ;
Nakayama, K ;
Ohki, M .
GENOMICS, 1996, 35 (01) :196-206
[2]   LOSS OF HETEROZYGOSITY OCCURS AT THE D11S29 LOCUS ON CHROMOSOME 11Q23 IN INVASIVE CERVICAL-CARCINOMA [J].
BETHWAITE, PB ;
KORETH, J ;
HERRINGTON, CS ;
MCGEE, JOD .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :814-818
[3]  
CARTER SL, 1994, CANCER RES, V54, P6270
[4]  
Dahiya R, 1997, INT J CANCER, V72, P283, DOI 10.1002/(SICI)1097-0215(19970717)72:2<283::AID-IJC14>3.0.CO
[5]  
2-H
[6]  
Davis M, 1996, CANCER RES, V56, P741
[7]   Heterozygous ATM mutations do not contribute to early onset of breast cancer [J].
FitzGerald, MG ;
Bean, JM ;
Hegde, SR ;
Unsal, H ;
MacDonald, DJ ;
Harkin, DP ;
Finkelstein, DM ;
Isselbacher, KJ ;
Haber, DA .
NATURE GENETICS, 1997, 15 (03) :307-310
[8]   LOSS OF HETEROZYGOSITY AND AMPLIFICATION ON CHROMOSOME-11Q IN HUMAN OVARIAN-CANCER [J].
FOULKES, WD ;
CAMPBELL, IG ;
STAMP, GWH ;
TROWSDALE, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (02) :268-273
[9]  
Gabra H, 1996, CANCER RES, V56, P950
[10]   LOSS OF HETEROZYGOSITY ON THE LONG ARM OF CHROMOSOME-11 IN COLORECTAL TUMORS [J].
GUSTAFSON, CE ;
YOUNG, J ;
LEGGETT, B ;
SEARLE, J ;
CHENEVIXTRENCH, G .
BRITISH JOURNAL OF CANCER, 1994, 70 (03) :395-397